SPLN STARPHARMA HOLDINGS LIMITED

Unknown sector · Pharmaceuticals, Biotechnology & Life Sciences

—

52wk — – —

Overall

—

Value

—

Growth

—

Health

—

Quality

—

Momentum

—

Dividend

—

Price

About STARPHARMA HOLDINGS LIMITED

No company description available yet — run a data update.

Financial statements

Loading…

Scoring breakdown (4 Aug 2026)

Value —

Trailing P/E

—

Forward P/E

—

PEG ratio

—

EV / EBITDA

—

Price / Book

—

Price / Sales

—

Growth —

Revenue growth (1y)

—

Revenue CAGR (3y)

—

EPS growth (1y)

—

EPS CAGR (3y)

—

Financial Health —

Net debt / EBITDA

—

Interest coverage (EBIT/interest)

—

Current ratio

—

Debt / Equity

—

Quality (Profitability & Cash Flow) —

Return on equity

—

Return on assets

—

Operating margin

—

Net margin

—

Cash conversion (OCF / net income)

—

Dividend / Income —

No meaningful dividend — pillar excluded from the overall score.

Momentum —

6-month return vs ASX 200

—

Price vs 200-day average

—

Price vs 50-day average

—

Position in 52-week range

—

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history

Key metrics

Market cap

—

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

—

Dividend yield

—

Payout ratio

—

Beta

—

EV / EBITDA

—

Price / Book

—

ROE

—

Operating margin

—

Net margin

—

Total cash

—

Total debt

—

Current ratio

—

Debt / Equity

—

Free cash flow

—

Avg volume

—